Related Experiment Videos
Multiple drug therapy for disseminated malignant tumours
British Medical Journal
|November 6, 1971
Summary
This study on cancer treatment found that using multiple drugs for short durations achieved significant tumor regression in half of the patients. This approach minimized toxicity and hospital stays for cancer patients.
Area of Science:
- Oncology
- Pharmacology
- Clinical Medicine
Background:
- Disseminated malignant tumors present a significant treatment challenge.
- Conventional multi-drug chemotherapy regimens can be associated with substantial toxicity and prolonged hospitalization.
Purpose of the Study:
- To evaluate the efficacy and safety of a novel short-term, intensive multi-drug chemotherapy regimen for patients with disseminated malignant tumors.
- To assess if this treatment approach can achieve tumor regression with reduced toxicity and shorter hospital stays.
Main Methods:
- Forty patients with various disseminated malignant tumors were enrolled.
- Treatment involved up to six anticancer drugs administered over a period not exceeding 24 hours.
- Objective tumor regression and treatment toxicity were closely monitored.
Main Results:
- Complete or partial objective tumor regression was observed in 20 out of 40 patients (50%).
- The treatment regimen demonstrated efficacy comparable to other multi-drug approaches.
- Significant advantages included minimized toxicity, with no severe bone marrow depression, and reduced hospitalization time.
Conclusions:
- Short-term, intensive multi-drug chemotherapy is an effective treatment for disseminated malignant tumors.
- This regimen offers a favorable toxicity profile and improved patient convenience compared to traditional methods.
- Further research into optimizing drug combinations and treatment durations is warranted.